The course will briefly discuss the general preclinical/tox data requirements for the new drug application. The course will also provide understanding of the terminology, regulations and mandated practices for GLP testing and compliance. Special attention will be paid to the critical compliance aspects of gathering pre-clinical data in a regulated environment.
Areas Covered in the Session:
The role of Preclinical/Safety/Tox studies during the drug clinical development and NDA.
General requirements for preclinical studies;
GLP principles.
Webinar Includes:
Get a chance to attend the Q/A Session with the Expert to ask your toughest question
PDF print only copy of PowerPoint slides
60 Minutes Live Presentation
Official Website: https://compliance2go.com/index.php?option=com_training&speakerkey=36&productKey=180
Added by Jay Sylvester on September 27, 2012